GMP-compliant automated synthesis and quality control of [177Lu]Lu-PSMA-I&T using the GAIA/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancer

Abstract Background Prostate cancer (PCa) has been identified as the most prevalent form of cancer among males and the third leading cause of death from cancer in the European male population. Early-stage PCa can be treated with prostatectomy and radiotherapy, whereas metastatic cases require androg...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Amélie Coussirou, Mélodie Six, Agathe Edet-Sanson, Alice Salles, Pierre Vera, David Tonnelet, Pierre Bohn
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SpringerOpen 2026-05-01
coleção:	EJNMMI Radiopharmacy and Chemistry
Assuntos:	Prostate cancer Lutetium PSMA-I&T Radioligand therapy Experimental drug
Acesso em linha:	https://doi.org/10.1186/s41181-026-00455-x
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!